Dissemin is shutting down on January 1st, 2025

Published in

BMJ Publishing Group, Journal for ImmunoTherapy of Cancer, S3(2), 2014

DOI: 10.1186/2051-1426-2-s3-p79

Links

Tools

Export citation

Search in Google Scholar

CITN-06: a Phase I/expansion trial of alt-803, an IL-15 superagonist, in patients with advanced melanoma

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO